Summary
Recent advances in the transgenetics of prion diseases and Alzheimer’s disease have led to a clearer understanding of the relationship between these two diseases and the pathogenic mechanisms underlying the two disorders. Earlier studies of transgenic mice expressing prion protein (PrP) underscored the importance of PrP levels and PrP primary structure on the resultant phenotype. Three major parameters influencing the phenotypes of mice expressing the Alzheimer amyloid precursor protein (APP) have also been identified: 1) APP levels; 2) APP primary structure; and 3) mouse host strain. The effects and implications of these parameters in transgenic mice expressing APP are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brown P, Goldfarb LG, McCombie WR, Nieto A, Squillacote D, Sheremata W, Little BW, Godec MS, Gibbs CJJ, Gajdusek DC (1992) Atypical Creutzfeldt-Jakob disease in an American family with an insert mutation in the PRNP amyloid precursor gene. Neurology 42: 422–7
Brown P, Gibbs CJJ, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35: 513–529
Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577–582
Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339–1347
Buxbaum JD, Christensen JL, Ruefli AA, Greengard P, Loring JF (1993) Expression of APP in brains of transgenic mice containing the entire human APP gene. Biochem Biophys Res Commun 197: 639–645
Cai X-D, Golde TE, Younkin SG (1993) Release of excess amyloid ß protein from a mutant amyloid ß protein precursor. Science 259: 514–516
Chartier-Harlin M-C, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M (1991) Early-onset Alzheimer’s disease caused by mutations at codon 717 of the ß-amyloid precursor protein gene. Nature 353: 844–846
Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature 360: 672–674
Collinge J, Owen F, Poulter M, Leach M, Crow TJ, Rossor MN, Hardy J, Mullan MJ, Janota I, Lantos PL (1990) Prion dementia without characteristic pathology. Lancet 336: 7–9
Collinge J, Whittington MA, Sidle KCL, Smith CJ, Palmer MS, Clarke AR, Jefferys JGR (1994) Prion protein is necessary for normal synaptic function. Nature 370: 295–297
Games D, Adams D, Alessandrini R, Barbour R, Berthelotte P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagoplan S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburh I, Little S, Masilah E, McConlogue L, Montoya-Zavaia M, Mucke L, Paganini L, Penalman E, Power M, Schenk D, Peubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimertype neuropathology in transgenic mice overexpressing V717F ß-amyloid precursor protein. Nature 373: 523–527
Goate A, Chartier-Harlin MA, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vances M, Roses A, Williamson R, Rossor M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706
Hendriks L, Duijn CMv, Cras P, Cruts M, Hul WV, Harskamp F v, Warren A, McInnis MG, Antonarakis SE, Martin J-J, Hofman A, Broeckhoven CV (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the ß-amyloid precursor protein gene. Nature Genet 1: 218–221
Higgins LS, Holtzman DM, Rabin J, Mobley WC, Cordell B (1994) Transgenic mouse brain histopathology resembles early Alzheimer’s disease. Ann Neurol 35: 598–607
Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J, Prusiner SB (1989) Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338: 342–345
Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587–1590
Hsiao KK, Groth D, Scott M, Yang S-L, Serban H, Rapp D, Foster D, Torchia M, DeArmond SJ, Prusiner SB (1994) Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci 91: 9126–9130
Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, Iadecola C, Clark HB, Carlson G (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15: 1203–1218
Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Youmkin S, Yang F, Cole G (1996) Correlative memory deficits, Aß elevation, and amyloid plagues in transgenic mice
Kammesheidt A, Boyce FM, Spanoyannis AF, Cummings BJ, Ortegon M, Cotman C, Vaught JL, Neve RL (1992) Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci USA 89: 10857–10861
Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond G J, Lansbury PT, Caughey B (1994) Cell-free formation of protease-resistant prion protein. Nature 370: 471–474
LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (1995) The Alzheimer’s Aß peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet 9: 21–30
Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, Pearson PL, Price DL, Gearhart JD (1993) Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genet 5: 22–30
Medori R, Montagna P, Tritschler HJ, LeBlanc A, Cortelli P, Tinuper P, Lugaresi E, Gambetti P (1992) Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 42: 669–670
Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L (1992) A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of ß-amyloid. Nature Genet 1: 345–347
Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease. Science 254: 97–99
Oesch B, Westaway D, Wälchli M, McKinley MP, Kent SBH, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, Prusiner SB, Weissmann C (1985) A cellular gene encodes scrapie PrP 27-30 protein. Cell 40: 735–746
Pan K-M, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB (1993) Conversion of a-helices into ß-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci 90:10962–10966
Pearson BE, Choi TK (1993) Expression of the human ß-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice. Proc Natl Acad Sci USA 90: 10578–10582
Price DL, Borchelt DR, Walker LC, Sisodia SS (1992) Toxicity of synthetic Aß peptides and modeling of Alzheimer’s disease. Neurobiol Aging 13: 623–625
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144
Prusiner SB (1985) Scrapie prions, brain amyloid, and senile dementia. Curr Top Cell Regul 26: 79–95
Prusiner SB (1992) Chemistry and biology of prions. Biochemistry 31: 12277–12288
Prusiner SB, Hsiao KK (1994) Human prion diseases. Ann Neurol 35: 385–395
Prusiner SB, Scott M, Foster D, Pan KM, Groth D, Mirenda C, Torchia M, Yang SL, Serban D, Carlson GA, Hoppe PC, Westaway D, DeArmond SJ (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673–686
Quon D, Wang Y, Catalano R, Scardina JM, Murakami K, Cordeil B (1991) Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 352: 239–41
Sandhu FA, Salim M, Zain SB (1991) Expression of the human ß-amyloid protein of Alzheimer’s disease specifically in the brains of transgenic mice. J Biol Chem 266: 21331–21334
Scott M, Foster D, Mirenda C, Serban D, Coufal F, Wälchli M, Torchia M, Groth D, Carlson G, DeArmond SJ, Westaway D, Prusiner SB (1989) Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59: 847–857
Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame AL, Prusiner SB (1993) Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32: 1991–2002
Suzuki N, Cheung TT, Cai XD, Okada A, Lotvos J, Eckman C, Golde TE, Younkin SG (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264: 1335–1340
Tateishi J, Doh-ura K, Kitamoto T, Tranchant C, Steinmetz G, Warter JM, Boellaard JW (1992) Prion protein gene analysis and transmission studies of Creutzfeldt-Jakob disease. In: Prusiner SB, Collinge J, Powell J, Anderton B (eds) Prion diseases of humans and animals. Ellis Horwood, London, pp 129–138
Westaway D, DeArmond SJ, Cayetano-Canias J, Groth D, Foster D, Yang S-L, Torchia M, Carlson GA, Prusiner SB (1994) Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic ice overexpressing wild-type prion proteins. Cell 76: 117–129
Yamaguchi F, Richards SJ, Beyreuther K, Salbaum M, Carlson GA, Dunnett SB (1991) Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. Neuroreport 2: 781–784
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag/Wien
About this paper
Cite this paper
Hsiao, K.K. (1997). From prion diseases to Alzheimer’s disease. In: Mizuno, Y., Youdim, M.B.H., Calne, D.B., Horowski, R., Poewe, W., Riederer, P. (eds) Advances in Research on Neurodegeneration. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6844-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6844-8_15
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82934-9
Online ISBN: 978-3-7091-6844-8
eBook Packages: Springer Book Archive